Twist Bioscience reported cash from operations of $1.11M and free cash flow of -$8.65M for the quarter ended Jun 2026, up 179.6% year over year. This cash flow statement covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||
| Net Income | -41.24M | -45.56M | -60.67M | -60.52M | -51.12M | -41.82M | -59.18M | -57.40M | -46.27M | -43.01M | -45.49M | -85.58M | -34.65M | -31.60M | -39.35M | 20.38M | -27.10M | -30.55M | -44.02M | -35.05M | |||||||||||||||
| Share-based CompensationStock Comp. | 3.38M | 72.51M | 4.61M | 2.54M | -2.33M | 10.26M | 10.60M | 11.75M | 11.02M | 13.82M | 13.73M | 12.35M | 11.99M | 20.33M | 16.06M | 16.08M | 24.77M | 18.94M | 18.18M | ||||||||||||||||
| Deferred Taxes | 10.54M | 0.50M | 0.13M | ||||||||||||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | |||||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 1.20M | 1.17M | 0.43M | 0.98M | 17.53M | 0.25M | 0.33M | 0.45M | 1.53M | 0.25M | 0.26M | 0.14M | 0.29M | ||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -34.80M | -46.65M | -42.34M | -34.12M | -1.27M | -54.07M | -44.29M | -23.41M | -20.70M | -22.97M | -19.42M | -6.38M | -15.32M | -21.43M | -12.99M | -1.40M | -11.81M | -24.81M | -17.56M | 1.11M | |||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 1.03M | -0.32M | -0.47M | 13.86M | 1.17M | ||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 2.48M | 3.15M | 3.97M | 4.44M | 4.95M | 5.29M | 7.03M | 8.49M | 8.50M | 8.17M | 8.30M | 8.30M | 6.66M | 6.38M | 6.40M | 6.07M | 6.00M | 6.19M | 6.41M | 6.78M | |||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.29M | 2.03M | 1.81M | 6.44M | -0.66M | 4.10M | 3.95M | -5.54M | 1.81M | -8.06M | 0.66M | -4.00M | 2.95M | 4.54M | 10.72M | -0.09M | 7.21M | -6.83M | 14.24M | 1.08M | |||||||||||||||
| Change in InventoryChange Inventory | 10.57M | 8.44M | 4.35M | -1.55M | -3.70M | 5.28M | -4.67M | -3.56M | -4.29M | -1.20M | -0.49M | -1.89M | -4.41M | -0.56M | -2.66M | 5.08M | 2.37M | 4.62M | 0.59M | 1.65M | |||||||||||||||
| Change in Account PayablesChange Payables | 3.35M | -0.01M | -0.76M | 1.23M | 6.92M | 3.28M | -7.49M | -0.22M | 1.92M | -4.21M | -1.52M | -1.20M | -4.88M | 5.71M | 0.71M | 3.19M | -0.28M | 1.47M | 0.07M | 3.04M | |||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 2.80M | -3.62M | 5.51M | 3.63M | -12.94M | -3.72M | 6.61M | -1.09M | 0.78M | -5.08M | 8.94M | 2.07M | 1.94M | -11.85M | 3.19M | 17.57M | -2.30M | -12.44M | 35.23M | 2.86M | |||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 8.09M | 12.78M | 31.97M | 40.64M | 16.46M | 11.82M | 9.05M | 4.51M | 2.39M | 1.51M | 0.60M | 0.96M | 2.00M | 2.27M | 4.14M | 9.16M | 12.43M | 9.97M | 7.89M | 9.76M | |||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | |||||||||||||||||||||||||||||||||||
| Acquisitions | 8.16M | ||||||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 32.00M | 12.00M | 18.68M | 44.80M | 25.00M | 27.50M | 78.00M | 31.00M | 18.24M | 24.00M | 6.00M | 2.00M | 21.91M | 21.32M | 7.65M | 21.16M | 20.55M | 5.00M | 12.80M | ||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 23.91M | -226.58M | -13.29M | 4.16M | 2.78M | -6.97M | 41.16M | 18.67M | -2.25M | 4.17M | -5.24M | -0.71M | -1.28M | -1.54M | -1.43M | -9.40M | -12.40M | -9.93M | -12.71M | -10.20M | |||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 3.10M | 266.71M | 0.01M | -0.00M | 0.60M | 0.25M | 0.35M | 0.17M | 0.95M | 1.32M | 2.92M | 1.92M | 2.95M | 0.77M | 1.83M | 3.79M | 0.30M | 1.79M | 3.79M | ||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 1.57M | -1.01M | 271.62M | -1.31M | 1.24M | -0.40M | 1.52M | -0.66M | 0.44M | -1.47M | 1.83M | 2.91M | 3.63M | 17.94M | 3.20M | 1.83M | 5.57M | 0.30M | 4.14M | 3.79M | |||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.17M | 0.17M | |||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | |||||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.13M | 0.08M | 0.02M | -0.10M | -0.32M | 0.27M | 0.07M | -0.32M | -0.05M | 0.12M | -0.07M | 0.00M | 0.07M | -0.05M | 0.10M | -0.07M | 0.16M | 0.01M | -0.01M | 0.01M | |||||||||||||||
| Change in Cash | -9.45M | -274.16M | 216.00M | -31.38M | 2.44M | -61.17M | -1.53M | -5.72M | -22.56M | -20.16M | -22.90M | -4.18M | -12.90M | -5.07M | -11.11M | -9.04M | -18.48M | -34.44M | -26.13M | -5.29M | |||||||||||||||
| Free Cash FlowFCF | -42.89M | -59.44M | -74.31M | -74.77M | -17.73M | -65.89M | -53.34M | -27.92M | -23.10M | -24.48M | -20.03M | -7.34M | -17.32M | -23.70M | -17.13M | -10.56M | -24.24M | -34.79M | -25.45M | -8.65M | |||||||||||||||
| Net Cash FlowNCF | -9.32M | -274.25M | 215.98M | -31.27M | 2.76M | -61.44M | -1.60M | -5.40M | -22.51M | -20.28M | -22.84M | -4.18M | -12.98M | -5.02M | -11.22M | -8.97M | -18.64M | -34.45M | -26.13M | -5.30M |